Directors' report

The AfroCentric Board of Directors presents its annual report for the year ended 30 June 2014.

Nature of business

The Company is a blackowned, diversified investment holding company which is listed on the JSE and trades in the Healthcare Sector under code ACT.

Business activities

The business activities of the Group are segmented into three diversified areas: AfroCentric Health, AfroCentric Technology and AfroCentric Resources.

AfroCentric Health

The majority stake held by AfroCentric (“the Company”) in AHL as at 30 June 2014 was 94.1% (2013: 94.07%).

AHL is one of the three areas of diversification for the Group. AHL owns 100% shareholding in the following subsidiaries:

Medscheme Holdings (Pty) Ltd

A wellknown and growing multimedical schemes administrator.

Helios IT Solutions (Pty) Ltd

Originally part of Medscheme, this business has now been independent and standalone for one financial year. The subsidiary provides healthcentric technology solutions.

Aid for Aids Management (Pty) Ltd

Specialists in AIDSrelated treatments for medical aids and corporate clients.

The business received accreditation from the Council for Medical Schemes in May 2012 and has been transferred out of Medscheme to form a new subsidiary.

AfroCentric Technology

Jasco Electronics Holdings Ltd

The Company holds a 20.27% minority interest in Jasco Electronics Holdings Limited (“Jasco”).

Jasco is listed on the JSE and provides solutions, services and products to customers through three core divisions, namely Information and Communication Technologies (“ICT”), Industry Solutions (“Industry”) and Energy Solutions (“Energy”).

ICT Solutions contains the telecommunications and information technology businesses of Jasco, Spescom, ARC Telecoms and the telecommunications arm of associate M-TEC.

Industry Solutions contains the security business and FerroTech.

Energy Solutions contains Electrical Manufacturers and Lighting Structures, as well as the energy arm of M-TEC.

This associate business diversifies the AfroCentric Technology area of the Group’s interests.

AfroCentric Resources

Rio Tinto Plc

Rio Tinto Plc is the third area of diversification for the Group under the AfroCentric Resources area. Rio Tinto is a world leader in exploration, mining and processing the earth’s mineral resources. AfroCentric has an exploration and prospecting relationship agreement with Rio Tinto in terms of the Reciprocal Strategic Cooperation Agreement.

Financial review

For the 2014 financial year, consolidated revenue increased by 10.62% to R1.96 billion.

The Group headline earnings increased by 42% to

R183.9 million compared to R129.6 million in the prior year and the diluted headline earnings per share increased by 67% to 47.83 cents per share (2013: 28.62 cents per share).

The activities and results of the Group are presented on pages 123 to 188.

Going concern

The annual financial statements have been prepared on the going concern basis. The Board of Directors has performed a review of the Group’s ability to continue as a going concern in the foreseeable future and therefore, based on this review, considers the preparation of the annual financial statements on this basis to be appropriate.

Dividends

In respect of the 2013 financial year a final dividend of 15 cents per ordinary share (gross) was declared and no preference dividend was provided for as the ordinary dividend was paid after the date on which the preference shares were converted or redeemed.

The Company declared a dividend of 18 cents per ordinary share for the year ended 30 June 2014. These dividends are subject to the Dividends Withholding Tax in terms of the Income Tax Act (Act No 58 of 1962, as amended) for which shareholders are liable.

In accordance with the provisions of the JSE Listings Requirements, the following additional information is disclosed:

the dividends have been declared out of profits available for distribution
the local Dividends Withholding Tax rate is 15%
the gross dividend amount is 18 cents per ordinary share
the STC credits available for utilisation is 0 cents per ordinary share
the net cash dividend amount is therefore 15.3 cents per ordinary share
for purposes of the distribution 467 855 101 ordinary shares will be deemed to be in issue on the dividend record date
the Company has 467 855 101 ordinary shares in issue on declaration date
the Company’s income tax reference number is 9600/148/71/3

Share capital

The Company’s share capital increased during the year from 270 010 639 to 467 855 101 ordinary shares due to the issuing of AfroCentric ordinary shares for the Executive Share Awards, second tranche transaction as well as the preference share redemption that took place during the year.

The details of the Company’s share capital are set out on note 19 on pages 169 and 170 of this report.

As per the Companies Act No 71 of 2008, section 38, the Board of Directors may resolve to issue shares of the Company at any time, but only within the classes, and to the extent, that the shares have been authorised by or in terms of the Company’s Memorandum of Incorporation.

Share repurchases

During the year, no share repurchases were made by the listed Company. AfroCentric Health Limited holds 1 072 451 treasury shares (2013: 580 874).

Audit and Risk committees

The information relating to the Audit and Risk committees is set out on pages 103 and 104.

Directors

The following information relates to the Directors of AfroCentric for the financial year ended 30 June 2014:

Director's name Date of
appointment
  Designation
AT Mokgokong (Chairman) 10 June 2010   Non-executive
NB Bam 20 December 2005   Non-executive
JM Kahn 20 December 2005   Non-executive
MI Sacks 20 December 2005   Non-executive
WRC Holmes 23 June 2010   Executive, salaried
MJ Madungandaba 10 June 2010   Non-executive
Y Masithela 1 September 2011   Independent non-executive
G Napier 1 September 2011   Independent non-executive
D Dempers 5 September 2012   Executive, salaried
JG Appelgryn 17 September 2013   Non-executive

Re-election of directors

Dr AT Mokgokong, Ms Y Masithela, Mr MJ Madungandaba and Mr G Napier will be standing for re-election at the forthcoming AGM.

Directors' ordinary shareholdings 2014

Director Direct beneficial   Indirect beneficial   Held by associate   Total   %  
AT Mokgokong (Chairman) 1 707 926   41 896 876   7 292 132   50 896 394   23.59  
NB Bam 150 000       150 000   0.07  
JM Kahn 18 535 608       18 535 608   8.60  
MI Sacks 17 579 938   3 760 000     21 339 938   9.89  
B Joffe          
WRC Holmes 1 353 846       1 353 846   0.63  
MJ Madungandaba   97 759 392   17 014 979   114 774 371   53.2  
Y Masithela          
G Napier          
D Dempers 7 626 810   876 242     8 503 052   3.94  
JG Appelgryn 181 447       181 447   0.08  
  47 135 575   144 292 510   24 307 111   215 735 196   100  

Directors' ordinary shareholdings 2013

Director Direct beneficial   Indirect beneficial   Held by associate   Total   %  
AT Mokgokong (Chairman) 1 707 926   27 730 649     29 438 575   24.42  
NB Bam 150 000       150 000   0.12  
JM Kahn 5 002 250       5 002 250   4.15  
MI Sacks 3 322 801   3 760 000     7 082 801   5.88   
B Joffe   3 600 000     3 600 000   2.99   
WRC Holmes          
MJ Madungandaba   64 704 849   9 215 925   73 920 774   61.33  
Y Masithela          
G Napier          
D Dempers 1 101 541   237 290     1 338 831   1.11  
  11 284 518   100 032 788   9 215 925   120 533 231   100  

Since the end of the financial year to the date of this report, the interests of Directors have remained unchanged.

A further detailed analysis of shareholders including majority shareholding is available on pages 119 to 120.

At the date hereof, none of the Directors have entered into a service contract with the Company except for Mr J Appelgryn who provides consulting services to the Group.

During the year under review, no material contracts in which Directors have an interest were entered into which significantly impacted the business of the Company.

Directors’ remuneration

Remuneration of Non-Executive Directors and Board Committee members

Non-Executive Directors received the following total remuneration for the year under review:

Director Fee
R'000
 
AT Mokgokong (Chairman) 797  
NB Bam 180  
JM Kahn *  
MI Sacks *  
J Appelgryn 135  
MJ Madungandaba 693  
Y Masithela 180  
G Napier 180  
*Messrs Kahn and Sacks waived their rights to receive any Directors' fees.

Remuneration of Executive and Non-Executive Directors

Details of the remuneration are set out fully in Note 30 of the Group annual financial statements.

Remuneration of the three highest paid employees who are not Directors

Employee Annual cost to company
R'000
 
K Aron 3 736  
T Rametse 3 149  
V Pillay 2 998  

Company Secretary and registered office

The role of Company Secretary was outsourced to Statucor (Pty) Ltd (“Statucor”) and the appointment was approved by the Board on 3 June 2013. The Board was satisfied that Statucor was suitably qualified for the position.

The Board was satisfied that Statucor (Pty) Ltd complied with section 87 of the Companies Act and that the Statucor team had the necessary skills and experience to be appointed as its Company Secretary. The Statucor team had an arm’s length relationship between itself and the Board, as required by the Companies Act. Statucor has since resigned as Company Secretary with effect from 28 February 2014.

Wilbert Mhlanga has been appointed as the Company Secretary with effect from 1 March 2014 and the Board is satisfied that Wilbert has the necessary skills and experience to be appointed as the Company Secretary. Wilbert has an arms length relationship with the Board as he is not a Board member.

Material resolutions

In terms of the JSE Listings Requirements the Company noted the material resolutions passed at the prior Annual General Meeting and during the financial year under review:

General approval to repurchase shares
Inter-company loans and other financial assistance
Fees payable to Non-Executive Directors
Financial statements for the financial year ended 30 June 2013
Audit report for the year ended 2013
Reappointment of independent registered auditors
Appointment of independent auditors via tender
Authority to determine remuneration
Election and re-election of Directors
Appointment of members to the Audit Committee
Control of authorised, but unissued shares
Approval to issue ordinary shares, and to sell treasury shares, for cash
Endorsement of the remuneration policy
Authority of Directors

Details of these resolutions can be obtained via the Company’s website or on request.

Material commitments, lease payments and contingent liabilities

No material capital commitments or lease payments have been contracted for or approved by the Board of Directors.

No contingent liabilities exist at the balance sheet date.

Litigation statement

In terms of the JSE Listings Requirements the Directors note that they are not aware of any legal or arbitration proceedings that are pending or threatened, that may have or have had in the recent past, being at least the previous 12 months, a material effect on the Group’s financial position, apart from the matters per Note 38 of the annual
financial statements.

Borrowing powers

In terms of the Memorandum of Incorporation, the borrowing powers of the Company are unlimited.

Insurance

The Group protects itself and the Directors against crime and professional indemnity by maintaining a comprehensive insurance programme.

Compliance

No events or actions during the financial year have led to the Group being non-compliant with the required laws and regulations relevant to the individual business units.

Auditor

PricewaterhouseCoopers Inc. and SizweNtsalubaGobodo Inc. have been appointed as joint auditors of the Company.

The Company’s interest in subsidiaries and associates:

Subsidiary Associate Nature of business Issued ordinary share
capital
June
2014
%
June
2013
%
 
AfroCentric Resources (Pty) Ltd   Dormant Less than 1000 100.00 100.00  
AfroCentric Capital (Pty) Ltd   Dormant Less than 1000 100.00 100.00  
ACT Healthcare Assets Investment (Pty) Ltd   Holding Less than 1000 100.00 100.00  
ACT Funding (Pty) Ltd   Financing Less than 1000 100.00 100.00  
Jasco Electronics Holdings Limited   ICT, Industy and Energy 44 263 793 20.27 27.30  
             

 
USEFUL LINKS

View our corporate website

 
E-BOOK

Use this link to view our Integrated Report as an E-Book

 
DOWNLOADS

This report is available to download as a full document and in sections.